Nystatin A3

Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.

Cross Reference

Introduction

To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Nystatin A3?

Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Nystatin A3

MeSH term MeSH ID Detail
Pregnancy Complications, Infectious D011251 11 associated lipids
Aspergillosis D001228 5 associated lipids
Leishmaniasis D007896 19 associated lipids
HIV Seropositivity D006679 15 associated lipids
Influenza, Human D007251 11 associated lipids
Vaginosis, Bacterial D016585 10 associated lipids
Candidiasis, Oral D002180 11 associated lipids
Mycoses D009181 18 associated lipids
Gonorrhea D006069 7 associated lipids
Xerostomia D014987 6 associated lipids
Per page 10 20 50 | Total 25

PubChem Associated disorders and diseases

What pathways are associated with Nystatin A3

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Nystatin A3?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Nystatin A3?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Nystatin A3?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Nystatin A3?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Nystatin A3?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Nystatin A3

Download all related citations
Per page 10 20 50 100 | Total 1594
Authors Title Published Journal PubMed Link
Mobasheri M et al. Solubilization Behavior of Polyene Antibiotics in Nanomicellar System: Insights from Molecular Dynamics Simulation of the Amphotericin B and Nystatin Interactions with Polysorbate 80. 2015 Molecules pmid:26712721
de Castro RD et al. Antifungal activity and mode of action of thymol and its synergism with nystatin against Candida species involved with infections in the oral cavity: an in vitro study. 2015 BMC Complement Altern Med pmid:26601661
Dewan E et al. Epidemiological and mycological characteristics of candidemia in patients with hematological malignancies attending a tertiary-care center in India. 2015 Hematol Oncol Stem Cell Ther pmid:26173033
de Castro RD et al. Use of alcohol vinegar in the inhibition of Candida spp. and its effect on the physical properties of acrylic resins. 2015 BMC Oral Health pmid:25928798
Cui H et al. Functional manipulations of the tetramycin positive regulatory gene ttmRIV to enhance the production of tetramycin A and nystatin A1 in Streptomyces ahygroscopicus. 2015 J. Ind. Microbiol. Biotechnol. pmid:26233316
Franiczek R et al. β-Aescin at subinhibitory concentration (sub-MIC) enhances susceptibility of Candida glabrata clinical isolates to nystatin. 2015 Med. Mycol. pmid:26092104
Bodin MB et al. Topical Nystatin for the Prevention of Catheter-Associated Candidiasis in ELBW Infants. 2015 Adv Neonatal Care pmid:25938952
Urban VM et al. Effect of the addition of antimicrobial agents on Shore A hardness and roughness of soft lining materials. 2015 J Prosthodont pmid:25082183
Sharifzadeh A et al. Evaluation of virulence factors and antifungal susceptibility patterns of different Candida species isolated from the female camel (Camelus dromedarius) genital tract. 2015 Mycoses pmid:26152466
Al-Shayyab MH et al. Antifungal prescribing pattern and attitude towards the treatment of oral candidiasis among dentists in Jordan. 2015 Int Dent J pmid:26148537
Rizk NN et al. Use of topical lidocaine, diphenhydramine hydrochloride, nystatin, and gabapentin swish in treatment for post-radiation neuropathy and oral mucositis. 2014 May-Jun Pain Physician pmid:24850125
Hemmateenejad B et al. Photodegradation study of nystatin by UV-Vis spectrophotometry and chemometrics modeling. 2014 Jul-Aug J AOAC Int pmid:25145159
Ren J et al. Enhancement of nystatin production by redirecting precursor fluxes after disruption of the tetramycin gene from Streptomyces ahygroscopicus. 2014 Jul-Aug Microbiol. Res. pmid:24231162
Gøtzsche PC and Johansen HK Nystatin prophylaxis and treatment in severely immunodepressed patients. 2014 Cochrane Database Syst Rev pmid:25188770
Johansen HK and Gøtzsche PC Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients. 2014 Cochrane Database Syst Rev pmid:25188769
Anil S et al. Sub-inhibitory concentrations of antifungals suppress hemolysin activity of oral Candida albicans and Candida tropicalis isolates from HIV-infected individuals. 2014 Mycopathologia pmid:25142726
Chulkov EG et al. Direct visualization of solid ordered domains induced by polyene antibiotics in giant unilamellar vesicles. 2014 Chem. Phys. Lipids pmid:25068758
Lewis M The role of antifungal and antiviral agents in primary dental care. 2014 Prim Dent J pmid:25668378
Ellepola AN et al. The postantifungal effect of nystatin and its impact on adhesion attributes of oral Candida dubliniensis isolates. 2014 Mycoses pmid:23773155
Li D et al. Efficacy and safety of probiotics in the treatment of Candida-associated stomatitis. 2014 Mycoses pmid:23952962
Kristanc L et al. The role of sterols in the lipid vesicle response induced by the pore-forming agent nystatin. 2014 Biochim. Biophys. Acta pmid:24863056
Serhan G et al. The polyene antifungals, amphotericin B and nystatin, cause cell death in Saccharomyces cerevisiae by a distinct mechanism to amphibian-derived antimicrobial peptides. 2014 Ann. Clin. Microbiol. Antimicrob. pmid:24884795
Mandigers PJ et al. The clinical significance of Cyniclomyces guttulatus in dogs with chronic diarrhoea, a survey and a prospective treatment study. 2014 Vet. Microbiol. pmid:24908274
Ruhil S et al. In vitro evaluation of combination of polyenes with EDTA against Aspergillus spp. by different methods (FICI and CI Model). 2014 J. Appl. Microbiol. pmid:24931000
Curvelo JA et al. Effect of the secretory leucocyte proteinase inhibitor (SLPI) on Candida albicans biological processes: a therapeutic alternative? 2014 Arch. Oral Biol. pmid:24907522
Hussein-Al-Ali SH et al. Antimicrobial and controlled release studies of a novel nystatin conjugated iron oxide nanocomposite. 2014 Biomed Res Int pmid:24900976
Rivarola de Gutierrez E et al. Topical treatment of oral lichen planus with anthocyanins. 2014 Med Oral Patol Oral Cir Bucal pmid:24880442
Lollis TR and Bradshaw WT Fungal prophylaxis in neonates: a review article. 2014 Adv Neonatal Care pmid:24472884
Ellepola AN and Samaranayake LP Impact of brief and sequential exposure to nystatin on the germ tube formation and cell surface hydrophobicity of oral Candida albicans isolates from human immunodeficiency virus-infected patients. 2014 Med Princ Pract pmid:24801278
Valitova J et al. Sterol binding by methyl-β-cyclodextrin and nystatin--comparative analysis of biochemical and physiological consequences for plants. 2014 FEBS J. pmid:24612537
Popa I et al. Expression and subcellular localization of RAGE in melanoma cells. 2014 Biochem. Cell Biol. pmid:24697697
Gitrowski C et al. Uptake of different crystal structures of TiOâ‚‚ nanoparticles by Caco-2 intestinal cells. 2014 Toxicol. Lett. pmid:24576787
Mansourian A et al. The comparative study of antifungal activity of Syzygium aromaticum, Punica granatum and nystatin on Candida albicans; an in vitro study. 2014 J Mycol Med pmid:25442923
Choukri F et al. In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents. 2014 J Mycol Med pmid:25442913
Piña-Vázquez C et al. Identification of phosphatidylcholine transfer protein-like in the parasite Entamoeba histolytica. 2014 Biochimie pmid:25223890
Boros-Majewska J et al. Novel Nystatin A₁ derivatives exhibiting low host cell toxicity and antifungal activity in an in vitro model of oral candidosis. 2014 Med. Microbiol. Immunol. pmid:24924305
Katyukhin LN A method for evaluation of membrane permeability for water by the erythrocyte osmotic deformability profiles. 2014 Bull. Exp. Biol. Med. pmid:24915951
Gerstein AC et al. Loss-of-heterozygosity facilitates passage through Haldane's sieve for Saccharomyces cerevisiae undergoing adaptation. 2014 Nat Commun pmid:24804896
Sheikh S et al. Fluorescence imaging of human cells with a novel conjugate of the antifungal nystatin. 2014 Med Chem pmid:24725140
Chukwuneke F et al. Concurrent Presentation of Burning Mouth Syndrome and Globus Pharyngis in Enugu, Nigeria: A Ten-year Clinical Evaluation. 2014 Oral Health Prev Dent pmid:24624402
Sklenár Z et al. Compounded preparations with nystatin for oral and oromucosal administration. 2013 Jul-Aug Acta Pol Pharm pmid:23923400
Giuliano S et al. Candidemia in Neurosurgical Intensive Care Unit: preliminary analysis of the effect of topical Nystatin prophylaxis and adequate source control on patients with early tracheostomy intubation. 2013 Jan-Feb Ann Ig pmid:23435780
Perez R et al. The effect of topically applied antimycotic agents on inner ear vestibular and cochlear function. 2013 Laryngoscope pmid:22991276
Manzoni P et al. Prevention of nosocomial infections in neonatal intensive care units. 2013 Am J Perinatol pmid:23292914
Ouyang W et al. Absence of death receptor translocation into lipid rafts in acquired TRAIL-resistant NSCLC cells. 2013 Int. J. Oncol. pmid:23258590
Perchyonok VT et al. Chitosan and gelatin based prototype delivery systems for the treatment of oral mucositis: from material to performance in vitro. 2013 Curr Drug Deliv pmid:23017090
Al-Jubory AR and Handy RD Uptake of titanium from TiOâ‚‚ nanoparticle exposure in the isolated perfused intestine of rainbow trout: nystatin, vanadate and novel COâ‚‚-sensitive components. 2013 Nanotoxicology pmid:23020080
Gerstein AC Mutational effects depend on ploidy level: all else is not equal. 2013 Biol. Lett. pmid:23054913
Thiessen N et al. [Squamous cell carcinoma developing in oral lichen planus]. 2013 Hautarzt pmid:24127014
Semis R et al. Mechanism of activity and toxicity of Nystatin-Intralipid. 2013 Med. Mycol. pmid:23088298